CHD/Prevention News

Short-interval high-intensity exercise after stroke improved oxygen consumption and may reduce risk for future strokes and hospitalizations, according to a study published in Stroke.

Metformin may protect against the progression of adverse renal and cardiovascular outcomes in patients systemic lupus erythematosus, including lupus nephritis and infarction, according to data published in ACR Open Rheumatology.

A remote postpartum blood pressure management program led to fewer hospital readmissions, greater postpartum visit attendance, improved guideline adherence and higher rates of antihypertensive prescriptions, researchers reported.

Latin American patients with rheumatoid arthritis experience fewer serious adverse events, including major adverse cardiovascular events and malignancy, than patients who are not Latin American, according to a study.

Bayer announced positive top-line results for the FINEARTS-HF trial of finerenone, in which the drug reduced risk for cardiovascular death and heart failure events in patients with HF with preserved or mildly reduced ejection fraction.

Decreased intake of extra-virgin olive oil within a whole-food, plant-based diet may help to lower LDL among individuals at risk for atherosclerotic CVD, according to a study published in Journal of the American Heart Association.

The number of monthly prescription fills for semaglutide increased by 442% from 2021 to 2023, according to a research letter published in JAMA Health Forum.

Risk for psychiatric disorder or suicide attempt is particularly high in the first year following hospitalization for heart disease, and patient support is important to lower such risk, researchers reported.

Obicetrapib significantly reduced LDL vs. placebo in adults with heterozygous familial hypercholesterolemia and uncontrolled LDL, despite maximally tolerated therapy, according to the top-line results of the phase 3 BROOKLYN clinical trial.

Elevated lipoprotein(a), despite a coronary artery calcium score of 0, could portend coronary plaque burden and may be a potential marker for early atherosclerosis intervention, researchers reported.